In appreciation of contributions to the industry and insight on interoperability solutions, Adaptive Clinical was pleased to be invited to the eSource Stakeholders Group Meeting held on March 18th, 2016 in Silver Springs Maryland. The purpose of the meeting was to...
Adaptive Clinical’s February 23rd Webinar on Clinical Trial Data Integration to Feature Dr. Roomi Nusrat Adaptive Clinical is pleased to be working with Dr. Roomi Nusrat, MD, in providing information and guidance on the case for improved clinical trial data...
In 2013, the FDA released its final guidance on the use of Electronic Source Data in clinical investigations. In short, the premise of the guidance is that capturing clinical data digitally is better for all parties involved in the research activities. The industry...
The cost of pharmaceutical products is among the fastest growing components of health care costs today. A major contributing factor to those costs are the research and development departments aimed at discovering, developing, and commercializing new pharmaceutical...
The clinical trials industry has been slow to adopt technology, despite the abundance of new technologies that have emerged over the past decade and the rate of adoption by consumers. In the early 2000s, clinical trials began moving from paper and forms processing...
The statistics are overwhelming. Every successfully approved FDA treatment starts with the researching of thousands of potential treatments, can take anywhere from four to eight years of research and 1 to 2 years of FDA review, and cost upwards of $500 million to $1...
